Abeona Therapeutics ABEO
NASDAQ ABEO
$6.01 +0.08 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Abeona Therapeutics (ABEO) Net Margin Growth (5y) (2016 - 2025)

Analysis

Abeona Therapeutics (ABEO) Net Margin Growth (5y) (2016 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Abeona Therapeutics 342.29 Mn 195.46 Mn 7.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -12,291.00
Jun 30, 2023 396,004.00
Dec 31, 2022 -480,784.00
Jun 30, 2022 302,731.00
Mar 31, 2022 -318,828.00
Dec 31, 2020 55,944.00
Sep 30, 2020 202,266.00
Dec 31, 2018 888,622.00
Sep 30, 2018 -48,508.00
Jun 30, 2018 -462,152.00
Mar 31, 2018 -225,707.00
Dec 31, 2017 -746,072.00
Sep 30, 2017 -68,186.00
Jun 30, 2017 -221,535.00
Mar 31, 2017 -253,071.00
Dec 31, 2016 -269,467.00
Sep 30, 2016 -141,677.00
Jun 30, 2016 -199,491.00
Mar 31, 2016 -80,115.00